Future directions in headache medicine will include the accurate clinical characterization of primary headaches and facial pain. This will require detailed clinical observation, the identification of migraine-specific biomarkers, and precise phenotyping using the latest technologies.
Marta Waliszewska-Prosół (Tue,) studied this question.